TSHA Maintained by B of A Securities -- Price Target Raised to $10.00
B of A Securities analyst Tazeen Ahmad maintained a 'Buy' rating on Taysha Gene Therapies (TSHA), increasing the price target from $9.00 to $10.00, suggesting an 11.11% potential upside. Despite this optimistic outlook, GuruFocus indicates that TSHA is significantly overvalued by 832.9% with a low GF Score™ of 27, and recent insider activity shows $0.9 million in stock divestments. This creates a mixed picture for investors, highlighting analyst confidence alongside concerns about valuation and underlying financial weaknesses.
TD (TD) launches callable barrier notes paying ~9.05% contingent coupon
The Toronto-Dominion Bank (TD) has launched Callable Contingent Interest Barrier Notes linked to the Nasdaq-100, Russell 2000, and S&P 500 indices, offering an annual contingent interest rate of approximately 9.05%. These notes mature on June 23, 2028, and pay monthly interest if each underlying index is at or above 75% of its initial value, but investors risk losing principal if any index falls below 70% of its initial value at maturity. TD can call the notes monthly starting from the sixth payment date, which introduces reinvestment risk for investors.
Japan Post Holdings sells $385,833 in Aflac stock
Japan Post Holdings Co., Ltd. recently sold 3,300 shares of Aflac Inc. common stock for a total of $385,833, with shares trading near their 52-week high. Following the transactions, Japan Post Holdings still indirectly holds over 50 million Aflac shares through the J&A Alliance Trust. This sale follows Aflac's Q1 2026 earnings report, which showed a revenue beat despite a slight EPS miss, and the company's shareholders' approval of most proposals at their annual meeting.
Jim Cramer Says He “Can’t Think of a Reason to Own Tractor Supply”
Jim Cramer expressed skepticism about investing in Tractor Supply Company (NASDAQ: TSCO), citing concerns that the post-COVID rural migration trend, which boosted the company, is over. He suggested there's no compelling reason to own the stock, other than a potential takeover, despite its 3% yield and its stock being down over 50%. Cramer also noted that consumers can find similar products cheaper online, reducing the need to shop at Tractor Supply.
How Kroger is leaning on pricing and stores to reset its value proposition
Kroger's new CEO, Greg Foran, is prioritizing improving the shopper experience and clarifying the company's value proposition. He aims to simplify pricing, make stores more competitive, and enhance operational efficiency to rebuild customer trust and market share, despite a recent dip in stock performance. Foran also plans to aggressively expand Kroger's store fleet to keep pace with rivals.
Hormel Chili No Beans from Hormel Foods Corp. - chunky 425 g can keeps classic recipe alive
Hormel Chili No Beans, a longstanding product from Hormel Foods Corp., maintains its classic chunky beef and pork recipe in a 425g can. It caters to consumers seeking quick and hearty chili for various dishes like chili dogs and nachos, offering a mild spice level and convenience. The article also touches upon Hormel Foods' broader strategy of owning mealtime occasions and its stock market position (NYSE: HRL).
NVIDIA vs. Apple: Which Tech Titan Is the Better Buy Right Now?
This article compares NVIDIA (NVDA) and Apple (AAPL) as investment opportunities. While NVIDIA leads the AI infrastructure market with massive growth and a premium valuation, Apple presents a more attractive risk-reward profile due to its consistent ecosystem growth, strong financial performance, emerging AI strategy, and a more reasonable valuation. The analysis concludes that Apple is currently the better buy for investors prioritizing a balance of growth, stability, and valuation.
US Private Credit: Blackstone, Apollo, FS KKR take control of Medallia
Blackstone, Apollo, and FS KKR have taken ownership of Medallia, signaling a growing influence of private credit in corporate financing. The transaction aims to stabilize Medallia's financial structure through a capital injection, supporting strategic initiatives and long-term investment in AI-driven innovation. This move emphasizes balance sheet improvements and operational stability, highlighting how private credit firms are actively shaping corporate outcomes.
TELEO Capital Acquires Applied Materials’ Pharmaceutical Manufacturing Intelligence Platform
TELEO Capital Management, LLC has acquired SmartFactory Rx, a pharmaceutical manufacturing intelligence platform, from Applied Materials, Inc. The platform, now rebranded as Modersys, is designed to help biopharmaceutical and life sciences companies improve manufacturing efficiency, reduce variability, and accelerate time to market through real-time analytics and AI/ML process intelligence. TELEO Capital states that Modersys will now have the necessary focus and investment to accelerate product innovation to meet global customer demands.
Global insurance protection gap widens as growth shifts to emerging markets: Moody’s
Moody's reports that the global insurance protection gap is expanding due to economic growth moving towards underinsured emerging markets and increasing uninsured catastrophe losses. While developed economies generally have narrower gaps, significant variations exist within countries and across risk types, influenced by factors like product availability and affordability. The report also highlights that major disasters can initially increase insurance demand, but repeated losses can lead to higher costs and reduced coverage, further widening the gap, especially with new regions experiencing extreme weather.








